Skip to main content
SpringerLink
Log in
Book cover

Valvular Heart Disease pp 71–101Cite as

Comprehensive Approach to Aortic Valve Disease

  • Chapter
  • First Online:

  • 1269 Accesses

Part of the book series: Cardiovascular Medicine ((CVM))

Abstract

This chapter presents a broad overview of aortic stenosis and aortic regurgitation. Each is discussed in detail, with an emphasis on etiology, pathophysiology, clinical presentation, diagnostic imaging, and medical and mechanical therapy. Imaging, a key to the understanding and diagnosis of valvular heart disease, is emphasized and over 30 echocardiograms are presented. All valve diseases are mechanical problems requiring mechanical solutions. Accordingly, surgical aortic valve replacement is widely discussed while transcatheter valve replacement is discussed extensively in Chap. 10. The intent of the chapter is for the reader to have extensive resource document that will present authoritative answers to typical clinical questions about aortic valve disease.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O’Brien KD. Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis: histological and immunohistochemical studies. Circulation. 1994;90:844–53.

    Article  CAS  PubMed  Google Scholar 

  2. Toutouzas K, Drakopoulou M, Synetos A, Tsiamis E, et al. In vivo aortic valve thermal heterogeneity in patients with nonrheumatic aortic valve stenosis the: first in vivo experience in humans. J Am Coll Cardiol. 2008;52(9):758–63.

    Article  PubMed  Google Scholar 

  3. Cowell SJ, Newby DE, Prescott RJ, Bloomfiend P, Reid J, Northridge DB, Boon NA, Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;352:2389–97.

    Article  CAS  PubMed  Google Scholar 

  4. Rossebo AB, Pederson TR, Bowan K, Brudi P, et al. SEAS Investigators. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359:1343–56.

    Article  PubMed  Google Scholar 

  5. Chan KL, Teo K, Dumsnil JG, Ni A Tam J, Investigators ASTRONOMER. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation. 2010;121:306–14.

    Article  CAS  PubMed  Google Scholar 

  6. Puri R, Nocholls SJ, Shao M, Kataoka Y, et al. Impact of strains on serial coronary calcification during atheroma progression and regression. J Am Coll Cardiol. 2015;65(13):1273–82.

    Article  CAS  PubMed  Google Scholar 

  7. Wu B, Elmariah S, Kaplan FS, Cheng G, Mohler ER III. Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: implications for end-stage valvular heart disease. Arterioscler Thromb Vasc Biol. 2005;25:592–7.

    Article  CAS  PubMed  Google Scholar 

  8. Kamstrup PR, Tybjaerg-Hansen A, Nordestgaard BG. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. J Am Coll Cardiol. 2014;63(5):470–7.

    Article  CAS  PubMed  Google Scholar 

  9. Wirrig EE, Yutzey KE. Conserved transcriptional regulatory mechanisms in aortic valve development and disease. Arterioscler Thromb Vasc Biol. 2014;34(4):737–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ikonomidis JS, Ruddy JM, Benton SM Jr, Arroyo J, et al. Aortic dilatation with bicuspid aortic valves: cusp fusion correlates to matrix metalloproteinases and inhibitors. Ann Thorac Surg. 2012;93:457–63.

    Article  PubMed  Google Scholar 

  11. Russo CF, Cannata A, Lanfranconi M, Vitali E, Garatti A, Bonacina E. Is aortic wall degeneration related to bicuspid aortic valve anatomy in patient with valvular disease? J Thorac Cardiovasc Surg. 2008;136:937–42.

    Article  PubMed  Google Scholar 

  12. Guzzardi DG, Barker AJ, van Ooij P, Malaisrie SC, et al. Valve-related hemodynamics mediate human bicuspid aortopathy: insights from wall shear stress mapping. J Am Coll Cardiol. 2015;66:892–900.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Siu SC, Silversides CK. Bicuspid aortic valve disease. J Am Coll Cardiol. 2010;55:2789–800.

    Article  PubMed  Google Scholar 

  14. Spinale FG, Bolger A. Fate versus flow. Wall shear stress in the aortopathy associated with bicuspid aortic valves. J Am Coll Cardiol. 2015;66:901–4.

    Article  PubMed  Google Scholar 

  15. Ross J Jr, Braunwald E. Aortic stenosis. Circulation. 1968;38:61–7.

    Article  PubMed  Google Scholar 

  16. Leon MB, Smith CR, Mack M. Miller DC, Moses JW, et al. PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patient who cannot undergo surgery. N Engl J Med. 2010;363(71):1597–607.

    Google Scholar 

  17. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, et al. U.S. CoreValve Clinical Investigators. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. N Engl J Med. 2014;370(19):1790–8.

    Google Scholar 

  18. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975;56:56–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Kupari M, Turto H, Lommi J. Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure. Eur Heart J. 2005;26:1790–6. Epub 2005 Apr 28.

    Article  PubMed  Google Scholar 

  20. Marcus ML, Doty DB, Hiratzka LF, Wright CB, Easham CL. Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries. N Engl J Med. 1982;307:1362–6.

    Article  CAS  PubMed  Google Scholar 

  21. Nakano K, Corin WJ, Spann JFJ, Biederman RW, Denslow S, Carabello BA. Abnormal subendocardial blood flow in pressure overload hypertrophy is associated with pacing-induced subendocardial dysfunction. Circ Res. 1989;65:155–64.

    Article  Google Scholar 

  22. Breisch EA, White FC, Bloor CM. Myocardial characteristics of pressure overload hypertrophy: a structural and functional study. Lab Investig. 1984;51:333–42.

    CAS  PubMed  Google Scholar 

  23. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: part II—causal mechanisms and treatment. Circulation. 2002;105:1503–8.

    Article  PubMed  Google Scholar 

  24. Hess OM, Ritter M, Schneider J, Grimm J, Turina M, Krayenbuehl HP. Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement. Circulation. 1984;69:85–65.

    Article  Google Scholar 

  25. Weidemann F, Herrmann S, Stork S, Niemann M, et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation. 2009;120:577–84.

    Article  CAS  PubMed  Google Scholar 

  26. Ito K, Yan X, Feng X, Manning WJ, Dillman WH, Lorell BH. Transgenic expression of sarcoplasmic reticulum Ca++ ATPase modifies the transition from hypertrophy to early heart failure. Circ Res. 2001;89:422–9.

    Article  CAS  PubMed  Google Scholar 

  27. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the falling human heart. N Engl J Med. 1997;336:1131–41.

    Article  CAS  PubMed  Google Scholar 

  28. Carabello BA, Green LH, Grossman W, Cohn LH, Koster JK, Collins JJ Jr. Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure. Circulation. 2980;62:42–8.

    Article  Google Scholar 

  29. Carabello BA. Compendium: introduction to aortic stenosis. Circ Res. 2013;113(2):179–85.

    Article  CAS  PubMed  Google Scholar 

  30. Kadem L, Dumesnil JG, Rieu R, Durand LG, Garcia D, Pibarot P. Impact of systemic hypertension on the assessment of aortic stenosis. Heart. 2005;91(3):354–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Carabello BA. Georg Ohm and the changing character of aortic stenosis: it’s not your grandfather’s Oldsmobile. Circulation. 2012;125:2295–7.

    Article  PubMed  Google Scholar 

  32. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD, American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):2438–88.

    Google Scholar 

  33. Minners J, Allgeier M, Gohlke-Baerwolf C, Kienzle RP, Neumann FJ, Jander N. Inconsistencies of echocardiographic criteria for the grading of aortic valve stenosis. Eur Heart J. 2008;29(8):1043–8.

    Article  PubMed  Google Scholar 

  34. Herrmann S, Fries B, Liu D, Hu K, Stoerk S, Voelker W, Ruppert C, Lorenz K, Ertl G, Weidemann F. Differences in natural history of low- and high-gradient aortic stenosis from nonsevere to severe stage of the disease. J Am Soc Echocardiogr. 2015;28(11):1270–82.

    Article  PubMed  Google Scholar 

  35. Ito S, Miranda WR, Nkomo VT, et al. Reduced left ventricular ejection fraction in patients with aortic stenosis. J Am Coll Cardiol. 2018;71:1313–21.

    Article  PubMed  Google Scholar 

  36. Baicu CF, Zile MR, Aurigemma GP, Gaasch WH. Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure. Circulation. 2005;111(18):2306–12.

    Article  PubMed  Google Scholar 

  37. Brener SJ, Duffy CI, Thomas JD, Stewart WJ. Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction. J Am Coll Cardiol. 1995;25(2):305–10.

    Article  CAS  PubMed  Google Scholar 

  38. Otto CM, Pearlman AS, Gardner CL. Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography. J Am Coll Cardiol. 1989;13(3):545–50.

    Article  CAS  PubMed  Google Scholar 

  39. Rosenhek R, Rader F, Loho N, Gabriel H, Heger M, Klaar U, Schemper M, Binder T, Maurer G, Baumgartner H. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation. 2004;110(10):1291–5.

    Article  CAS  PubMed  Google Scholar 

  40. Moura LM, Ramos SF, Zamorano JL, Barros IM, Azevedo LF, Rocha-Gonçalves F, Rajamannan NM. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol. 2007;49(5):554–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Carabello BA. Aortic stenosis. In: Crawford MH, editor. Current diagnosis and treatment in cardiology. New York: Appleton & Lange; 1995. p. 87–98.

    Google Scholar 

  42. Clavel MA, Messika-Zeitoun D, Pibarot P, et al. The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study. J Am Coll Cardiol. 2013;62(24):2329–38.

    Article  CAS  PubMed  Google Scholar 

  43. Clavel MA, Malouf J, Messika-Zeitoun D, et al. Aortic valve area calculation in aortic stenosis by CT and Doppler echocardiography. JACC Cardiovasc Imaging. 2015;8(3):248–57.

    Article  PubMed  Google Scholar 

  44. Aggarwal SR, Clavel MA, Messika-Zeitoun D, et al. Sex differences in aortic valve calcification measured by multidetector computed tomography in aortic stenosis. Circ Cardiovasc Imaging. 2013;6(1):40–7.

    Article  PubMed  Google Scholar 

  45. Gorlin R, Gorlin SG. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. I. Am Heart J. 1951;41(1):1–29.

    Article  CAS  PubMed  Google Scholar 

  46. Dehmer GJ, Firth BG, Hillis LD. Oxygen consumption in adult patients during cardiac catheterization. Clin Cardiol. 1982;49:1860–7.

    Google Scholar 

  47. Khot UN, Novaro GM, Popovic ZB, Mills RM, Thomas JD, Tuzcu EM, Hammer D, Nissen SE, Francis GS. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med. 2003;348:1756–63.

    Article  CAS  PubMed  Google Scholar 

  48. Lindman BR, Zajarias A, Madrazo JA, Shah J, et al. Effects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosis. Circulation. 2012;125:2353–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Eleid MF, Nishimura RA, Sorajja P, Borlaug BA. Systemic hypertension in low-gradient severe aortic stenosis with preserved ejection fraction. Circulation. 2013;128:1349–53.

    Article  PubMed  Google Scholar 

  50. Nadir MA, Wei L, Elder DH, Libianto R, et al. Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis. J Am Coll Cardiol. 2011;58:570–6.

    Article  CAS  PubMed  Google Scholar 

  51. van Geldorp MWA, Jamieson WRE, Kappetein AP, Ye J, et al. Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg. 2009;137:881–6.

    Article  PubMed  Google Scholar 

  52. Pellikka PA, Sarano ME, Nishimura RA, Malouf JS, Bailey KR, Scott CG, Barnes ME, Tajik AJ. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation. 2005;111:3290–5.

    Article  PubMed  Google Scholar 

  53. Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur Heart J. 2005;26:1309–13. Epub 2005 Apr 8.

    Article  PubMed  Google Scholar 

  54. Amato M, Moffa PJ, Werner KE, Ramires JA. Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart. 2001;86:381–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Rosenhek R, Zilberszac R, Schemper M, Czerny M, Mundigler G, Graf S, Bergler-Klein J, Grim M, Gabiel H, Maurer G. Natural history of very severe aortic stenosis. Circulation. 2010;121(1):151–6.

    Article  PubMed  Google Scholar 

  56. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation. 1997;95(9):2262–70.

    Article  CAS  PubMed  Google Scholar 

  57. Bergler-Klein J, Klaar U, Heger M, Rosenhek R, Mundigler G, Gabriel H, Binder T, Pacher R, Maurer G, Baumgartner H. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation. 2004;109:2302–8.

    Article  CAS  PubMed  Google Scholar 

  58. Nessmith MG, Fukuta H, Brucks S, Little WC. Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients with aortic stenosis treated without surgery. Am J Cardiol. 2005;96:1445–8. Epub 2005 Oct 3.

    Article  CAS  PubMed  Google Scholar 

  59. Lim P, Monin JL, Monchi M, Garot J, Pasquet A, Hittinger L, Vanoverschelde JL, Carayon A, Gueret P. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. Eur Heart J. 2004;25:2048–53.

    Article  CAS  PubMed  Google Scholar 

  60. Steadman CD, Ray S, Ng LL, McCann GP. Natriuretic peptides in common valvular heart disease. J Am Coll Cardiol. 2010;55:2034–48.

    Article  CAS  PubMed  Google Scholar 

  61. Clavel MA, Malouf J, Michelena HI, Suri RM, Jaffe AS, Mahoney DW, Enriquez-Sarano M. B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival. J Am Coll Cardiol. 2014;63(19):2016–25.

    Article  CAS  PubMed  Google Scholar 

  62. Pereira JJ, Balaban K, Lauer MS, Lytle B, Thomas JD, Garcia MJ. Aortic valve replacement in patients with mild or moderate aortic stenosis and coronary bypass surgery. Am J Med. 2005;118:735–42.

    Article  PubMed  Google Scholar 

  63. Taniguchi T, Morimoto T, Shiomi H, Ando K, et al. CURRENT AS Registry Investigators. Initial surgical versus conservative strategies in patients with asymptomatic severe aortic stenosis J Am Coll Cardiol. 2015;66(25):2827–38.

    Article  PubMed  Google Scholar 

  64. Rahimtoola SH. Choice of prosthetic heart valve in adults an update. J Am Coll Cardiol. 2010;55(22):2413–26.

    Article  PubMed  Google Scholar 

  65. Dangas GD, Weitz JI, Giustino G, Makkar R, Mehran R. Prosthetic heart valve thrombosis. J Am Coll Cardiol. 2016;68(24):2670–89.

    Article  PubMed  Google Scholar 

  66. Phan K, Zhao DF, Zhou JJ, Karagaratnam A, Phan S, Yan TD. Bioprosthetic versus mechanical prostheses for valve replacement in end-stage renal disease patients: systematic review and meta-analysis. J Thorac Dis. 2016;8(5):769–77.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, et al. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013;369(13):1206–14.

    Article  CAS  PubMed  Google Scholar 

  68. Charitos EI, Takkenberg JJ, Hanke T, Gorski A, et al. Reoperations on the pulmonary autograft and pulmonary homograft after the Ross procedure: an update on the German Dutch Ross Registry. J Thorac Cardiovasc Surg. 2012;144(4):813–21, discussion 821–3.

    Article  PubMed  Google Scholar 

  69. El-Hamamsy I, Eryigit Z, Stevens LM, Sarang Z, et al. Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial. Lancet. 2010;376:524–31.

    Article  PubMed  Google Scholar 

  70. Pibarot P. Prosthesis-patient mismatch: definition, clinical impact, and prevention. Heart. 2006;92(8):1022–9.

    Article  CAS  PubMed  Google Scholar 

  71. Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, et al. SURTAVI Investigators. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376(14):1321–31.

    Google Scholar 

  72. Mack MJ, Acker MA, Gelijns AC, Overbey JR, et al. Cardiothoracic Surgical Trials Network (CTSN). Effect of cerebral embolic protection devices on CNS infarction in surgical aortic valve replacement: a randomized clinical trial. JAMA. 2017;318(6):536–47.

    Google Scholar 

  73. Perlman GY, Loncar S, Pollak A, Gilon D, Alcalai R, Planer D, Lotan C, Danenberg HD. Post-procedural hypertension following transcatheter aortic valve implantation: incidence and clinical significance. JACC Cardiovasc Interv. 2013;6:472–8.

    Article  PubMed  Google Scholar 

  74. Huber D, Grimm J, Koch R, Krayenbuehl HP. Determinants of ejection performance in aortic stenosis. Circulation. 1981;64:126–34.

    Article  CAS  PubMed  Google Scholar 

  75. Gunther S, Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation. 1979;59(4):679–88.

    Article  CAS  PubMed  Google Scholar 

  76. Tribouilloy C, Levy F, Rusinaru D, Guéret P, et al. Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J Am Coll Cardiol. 2009;53:1865–73.

    Article  PubMed  Google Scholar 

  77. Brogan WC, Grayburn PA, Lange RA, Hillis LD. Prognosis after valve replacement in patients with severe aortic stenosis and a low transvalvular pressure gradient. J Am Coll Cardiol. 1993;21:1657–60.

    Article  PubMed  Google Scholar 

  78. Connolly HM, Oh JK, Schaff HV, Roger VL, Osborn SL, Hodge DO, Tajik AJ. Severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunction: result of aortic valve replacement in 52 patients. Circulation. 2000;101:1940–6.

    Article  CAS  PubMed  Google Scholar 

  79. Monin JL, Monchi M, Petit H, Baleynaud S, et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation. 2003;108:319–24.

    Article  PubMed  Google Scholar 

  80. Quere JP, Monin JL, Levy F, Petit H, et al. Influence of preoperative left ventricular contractile reserve on postoperative ejection fraction in low-gradient aortic stenosis. Circulation. 2006;113:1738–44.

    Article  PubMed  Google Scholar 

  81. Nwaejike N, Mills K, Stables R, Field M. Balloon aortic valvuloplasty as a bridge to aortic valve surgery for severe aortic stenosis. Interact Cardiovasc Thorac Surg. 2015;20(3):429–35.

    Article  PubMed  Google Scholar 

  82. Kefer J, Gapira JM, Pierard S, De Meester C, Gurne O, Chenu P, Renkin J. Recovery after balloon aortic valvuloplasty in patients with aortic stenosis and impaired left ventricular function: predictors and prognostic implications. J Invasive Cardiol. 2013;25:235–41.

    PubMed  Google Scholar 

  83. Buermans HPJ, Redout EM, Schiel AE, Musters RJ, et al. Micro-array analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure. Physiol Genomics. 2005;21:314–223.

    Article  CAS  PubMed  Google Scholar 

  84. Koide M, Nagatsu M, Zile MR, Hamawaki M, et al. Premorbid determinants of left ventricular dysfunction in a novel model of gradually induced pressure overload in the adult canine. Circulation. 1997;95(6):1601–10.

    Article  CAS  PubMed  Google Scholar 

  85. Casale PN, Palacios IF, Abascal VM, Harrell L, Davidoff R, Weyman AE, Fifer MA. Effects of dobutamine on Gorlin and continuity equation valve areas and valve resistance in valvular aortic stenosis. Am J Cardiol. 1992;70(13):1175–9.

    Article  CAS  PubMed  Google Scholar 

  86. Nishimura RA, Grantham JA, Connolly HM, Schaff HV, Higano ST, Holmes DR Jr. Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation. 2002;106:809–13.

    Article  PubMed  Google Scholar 

  87. Carabello BA, Ballard WL, Gazes PC, Sahn SA, Heffner JF. Cardiology pearls. Philadelphia, PA: Hanley & Belfus; 1994.

    Google Scholar 

  88. Fougeres E, Tribouilloy C, Monchi M, Petit-Eisenmann H, et al. Outcomes of pseudo-severe aortic stenosis under conservative treatment. Eur Heart J. 2012;33(19):2426–33.

    Article  PubMed  Google Scholar 

  89. Dumesnil JG, Pibarot P, Carabello BA. Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implication for diagnosis and treatment. Eur Heart J. 2010;31:281–9.

    Article  PubMed  Google Scholar 

  90. Hachicha Z, Dumensnil JG, Bogaty P, Pibarot P. Paradoxical low flow, low gradient severe stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation. 2007;115:2856–64.

    Article  PubMed  Google Scholar 

  91. Clavel MA, Dumesnil JG, Capoulade R, Mathieu P, Senchal M, Pibarot P. Outcome of patients with aortic stenosis, small valve area and low-flow, low-gradient despite preserved left ventricular ejection fraction. J Am Coll Cardiol. 2012;60:1259–67.

    Article  PubMed  Google Scholar 

  92. Clavel MA, Berthelot-Richer M, Le Ven F, Capoulade R, Dahou A, Dumesnil JG, Mathieu P, Pibarot P. Impact of classic and paradoxical low flow on survival after aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol. 2015;65(7):645–53.

    Article  PubMed  Google Scholar 

  93. Herrmann S, Störk S, Niemann M, Lange V, et al. Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome. J Am Coll Cardiol. 2011;58(4):402–12.

    Article  PubMed  Google Scholar 

  94. Dayan V, Vignolo G, Magne J, Clavel MA, Mohty D, Pibarot P. Outcome and impact of aortic valve replacement in patients with preserved LVEF and low-gradient aortic stenosis. J Am Coll Cardiol. 2015;66(23):2594–603.

    Article  PubMed  Google Scholar 

  95. Waller BF, Howard J, Fess S. Pathology of aortic valve stenosis and pure aortic regurgitation: a clinical morphologic assessment—part II. Clin Cardiol. 1994;17:150–6.

    Article  CAS  PubMed  Google Scholar 

  96. Wisenbaugh T, Spann JF, Carabello BA. Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation. J Am Coll Cardiol. 1984;3(4):916–23.

    Article  CAS  PubMed  Google Scholar 

  97. Taniguchi K, Nakano S, Hirose H, Matsuda H, Shirakura R, Sakai K, Kawamoto T, Sakaki S, Kawashima Y. Preoperative left ventricular function: minimal requirement for successful late results of valve replacement for aortic regurgitation. J Am Coll Cardiol. 1987;10(3):510–8.

    Article  CAS  PubMed  Google Scholar 

  98. Feiring AJ, Rumberger JA. Ultrafast computed tomography analysis of regional radius-to-wall thickness ratios in normal and volume-overloaded human left ventricle. Circulation. 1992;85(4):1423–32.

    Article  CAS  PubMed  Google Scholar 

  99. Schwarz F, Flameng W, Schaper J, Langebartels F, Sesto M, Hehrlein F, Schlepper M. Myocardial structure and function in patients with aortic valve disease and their relation to postoperative results. Am J Cardiol. 1978;41(4):661–9.

    Article  CAS  PubMed  Google Scholar 

  100. Krayenbuehl HP, Hess OM, Monrad ES, Schneider J, Mall G, Turina M. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation. 1989;79(4):744–55.

    Article  CAS  PubMed  Google Scholar 

  101. Sampat U, Varadarajan P, Turk R, Kamath A, Khandhar S, Pai RG. Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients. J Am Coll Cardiol. 2009;54:452–7.

    Article  PubMed  Google Scholar 

  102. Scognamiglio R, Rahimtoola S, Faoli G, Nistri S, Dalla Volta S. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med. 1994;331:689–94.

    Article  CAS  PubMed  Google Scholar 

  103. Evangelista A, Tornos P, Samola A, Permanyer-Miralda G, Soler-Soler J. Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med. 2005;353:1342–9.

    Article  CAS  PubMed  Google Scholar 

  104. Greenberg B, Massie B, Bristow JD, Cheitlin M, Siemienczuk D, Topic N, Wilson RA, Szlachcic J, Thomas D. Long-term vasodilator therapy of chronic aortic insufficiency. A randomized double-blinded, placebo-controlled clinical trial. Circulation. 1988;78(1):92–103.

    Article  CAS  PubMed  Google Scholar 

  105. Bonow RO, Lakatos E, Maron BJ, Epsstein SE. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation. 1991;84(4):1625–35.

    Article  CAS  PubMed  Google Scholar 

  106. Bonow RO, Dodd JT, Maron BJ, O’Gara PT, White GG, McIntosh CL, Clark RE, Epstein SE. Long-term serial changes in left ventricular function and reversal of ventricular dilatation after valve replacement for chronic aortic regurgitation. Circulation. 1988;78(5 Pt 1):1108–20.

    Article  CAS  PubMed  Google Scholar 

  107. Borer JS, Bonow RO. Contemporary approach to aortic and mitral regurgitation. Circulation. 2003;108:2432–8.

    Article  PubMed  Google Scholar 

  108. Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB. Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms. J Am Coll Cardiol. 1997;30:746–52.

    Article  CAS  PubMed  Google Scholar 

  109. Henry WL, Bonow RO, Rosing DR, Epstein SE. Observations on the optimum time for operative intervention for aortic regurgitation. II. Serial echocardiographic evaluation of asymptomatic patients. Circulation. 1980;61(3):484–92.

    Article  CAS  PubMed  Google Scholar 

  110. Chaliki HP, Mohty D, Avierinos JF, Scott CG, Schaff HV, Tajik AJ, Enriquez-Sarano M. Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation. 2002;106:2687–93.

    Article  PubMed  Google Scholar 

  111. Mentias A, Feng K, Alashi A, Rodriguez LL, et al. Long-term outcomes in patients with aortic regurgitation and preserved left ventricular ejection fraction. J Am Coll Cardiol. 2016;68(20):2144–53.

    Article  PubMed  Google Scholar 

  112. Silaschi M, Conradi L, Wendler O, Schlingloff F, et al. The JUPITER registry: one-year outcomes of transapical aortic valve implantation using a second generation transcatheter heart valve for aortic regurgitation. Catheter Cardiovasc Interv. 2018;91(7):1345–51.

    Article  PubMed  Google Scholar 

  113. Komya TA. Aortic valve repair update. Gen Thorac Cardiovasc Surg. 2015;63(6):309–19.

    Article  Google Scholar 

  114. Saczkowski R, Malas T, Kerchove L, El Khoury G, Boodhwanim M. Systematic review of aortic valve preservation and repair. Ann Cardiothorac Surg. 2013;2:3–9.

    PubMed  PubMed Central  Google Scholar 

  115. Carabello BA. Aortic regurgitation: hemodynamic determinants of prognosis. In: Cohn LC, DiSesa VJ, editors. Aortic regurgitation. New York: Marcel Dekker; 1986. p. 89–104.

    Google Scholar 

  116. Funakoshi S, Kaji S, Yamamuro A, Tani T, Kinoshita M, Okada Y, Furukawa YJ. Impact of early surgery in the active phase on long-term outcomes in left-sided native valve infective endocarditis. Thorac Cardiovasc Surg. 2011;142(4):836–42.

    Article  Google Scholar 

  117. Klieverik LM, Yacoub MH, Edwards S, Bekkers JA, Roos-Hesselink JW, Kappetein AP, Takkenberg JJ, Bogers AJ. Surgical treatment of active native aortic valve endocarditis with allografts and mechanical prostheses. Ann Thorac Surg. 2009;88(6):1814–21.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiology Division, Brody School of Medicine, East Carolina University, Greenville, NC, USA

    Blase A. Carabello

  2. Department of Cardiovascular Sciences, Vidant Medical Center, Greenville, NC, USA

    Blase A. Carabello & Rajasekhar Nekkanti

  3. Division of Cardiac Surgery, Department of Cardiovascular Sciences, East Carolina Heart Institute, Greenville, NC, USA

    Haziam Alwair

Authors
  1. Blase A. Carabello
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Haziam Alwair
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rajasekhar Nekkanti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Blase A. Carabello .

Editor information

Editors and Affiliations

  1. Brody School of Medicine, East Carolina University, Greenville, NC, USA

    Blase A. Carabello

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer-Verlag London Ltd., part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Carabello, B.A., Alwair, H., Nekkanti, R. (2020). Comprehensive Approach to Aortic Valve Disease. In: Carabello, B. (eds) Valvular Heart Disease. Cardiovascular Medicine. Springer, London. https://doi.org/10.1007/978-1-4471-2840-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2840-3_5

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2839-7

  • Online ISBN: 978-1-4471-2840-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation